Karo Healthcare Welcomes Sue Egstrand as New Chief Executive Officer

Karo Healthcare Welcomes New Leadership



Karo Healthcare has made a significant announcement with the appointment of Sue Egstrand as its new Chief Executive Officer, effective from January 1, 2027. This strategic move is aimed at enhancing the company’s growth trajectory as it seeks to establish itself among the top five consumer healthcare companies in Europe.

Egstrand comes to Karo with a wealth of experience in the healthcare and consumer sectors, having held various senior roles at renowned companies such as Pfizer, GlaxoSmithKline (GSK), and Reckitt. Notably, at Reckitt, she served as Senior Vice President of Europe Health, where she spearheaded regional strategies that resulted in impressive financial growth. Her most recent position was at Dechra, where she was President for Europe and International, and Chief Commercial Officer, overseeing critical commercial operations in the animal health sector.

Hans Arstad, Partner at KKR and Chairman of the Board at Karo Healthcare, expressed his enthusiasm regarding Egstrand's appointment. "We are thrilled to have Sue as our next CEO. Karo Healthcare has established a robust platform in the European consumer healthcare landscape, which presents vast opportunities for growth. Sue’s unique combination of industry experience and international leadership will help elevate Karo’s commercial endeavors and expand our operations across various markets," he stated.

In a statement reflecting her excitement about this new opportunity, Egstrand shared: "I am honored to join Karo at a pivotal moment for the company. Karo has cultivated a strong portfolio of reliable brands and possesses significant potential for future growth. I look forward to collaborating with the team to build on this impressive foundation, enhance our commercial capabilities, and ensure continuous momentum in our operations."

Egstrand takes over the role from Christoffer Lorenzen, who has led the company successfully. The Board expressed its gratitude to Lorenzen for his contributions to Karo Healthcare during his tenure.

Karo Healthcare, headquartered in Stockholm, is a prominent player in the European consumer healthcare market, dedicated to enhancing everyday health solutions that enable individuals to live life to the fullest. The company offers a diverse range of trusted brands, including Lamisil®, E45®, Pevaryl®, Proct®, Nutravita, Flux®, Multi-Gyn®, and Paracet®, and its products reach customers in over 90 countries. With a workforce of approximately 600 employees spread across 13 international hubs, Karo Healthcare aims to continue its innovative approach to consumer health solutions.

For more information about Karo Healthcare and its offerings, visit karohealthcare.com.

This appointment marks a critical step in Karo Healthcare’s mission to strengthen its market position and achieve greater heights in the realm of consumer healthcare, all under the guidance of its new CEO, Sue Egstrand.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.